George Clinical Accredited for Gene Technology Clinical Research

George Clinical Accredited for Gene Technology Clinical Research

SYDNEY, February 2, 2022 – George Clinical announces that the organization has been accredited by the Australian Office of the Gene Technology Regulator (OGTR) which allows it to be a licence holder for studies involving the use of genetically modified organisms (GMOs).  The addition of this capability  means that George Clinical can now, under the […]

Read More

February 2nd, 2022

George Clinical and Link Health Announce $40M in New Pharma Trials

Eight new pharmaceutical clinical trials with a value of more than $40 million are planned after the New South Wales government in Australia supported a joint venture between George Clinical and Guangzhou (China) based pharmaceutical company Link Health at the 28th biennial NSW-Guangdong Joint Economic Meeting. Minister for Trade and Industry Stuart Ayres said George […]

Read More

January 13th, 2022

George Clinical Receives Frost & Sullivan Best Practices Award for Improving Clinical Trial Efficiency and Patient-Centricity

Based on its recent analysis of the Asia-Pacific clinical contract research organization (CRO) industry, Frost & Sullivan recognizes George Clinical with the 2021 Asia-Pacific Competitive Strategy Leadership Award. As a leading APAC Clinical CRO company, George Clinical formulates solutions with innovation and scientific leadership to produce high-quality outcomes and maintain growth in the evolving CRO […]

Read More

January 13th, 2022

Insight from George Clinical Scientific Team on Leading the Global, Multi-Trial, Long-term ASCEND Program

The ASCEND program assessing the efficacy and safety of daprodustat for the treatment of anemia due to CKD across the CKD disease course is comprised of five Phase III studies. The program has enrolled over 8,000 patients who were treated for up to 4.26 years and spanned more than 35 countries. George Clinical was involved […]

Read More

January 11th, 2022

Noteworthy Renal Research Progress Highlighted by George Clinical Scientific Leaders During ASN Kidney Week

OVERLAND PARK, KS. November 11, 2021 – New kidney and metabolic research involving George Clinical teams and scientific leaders has received global attention during the 2021 American Society of Nephrology’s Kidney Week including contributions featured as abstracts, poster sessions, publications and presentations. Despite the restrictions of a global pandemic, meaningful renal clinical research has advanced […]

Read More

November 12th, 2021

George Clinical Shows Research Leadership during 2021 Kidney Week

George Clinical scientific leaders and staff members enjoyed significant involvement in the 2021 American Society of Nephrology’s Kidney Week including contributions to abstracts, poster sessions, publications and presentations.  Considering the organization’s deep history in kidney and metabolic clinical research, it is unsurprising yet inspiring to see such a broad set of renal research continuing despite […]

Read More

November 4th, 2021

Neuropharmacologist and CRO Veteran Graham Birrell Joins George Clinical to Lead APAC Operations

SYDNEY, October 14, 2021 – Graham Birrell, PhD, MBA, a researcher and neuropharmacologist with significant clinical research experience in the EU and Asia-Pacific region has joined George Clinical, a global scientifically-backed clinical research organization, as Head, Project Operations, APAC.  Birrell will also join the scientific leadership of George Clinical with a neurology focus. In his […]

Read More

October 19th, 2021

Scientific Leader Headlines George Clinical Involvement with IIGANN 2021

The International IgA Nephropathy Network held the 16th International Symposium on IgA Nephropathy September 21-23 and George Clinical scientific leader Professor Jonathan Barratt presented a key presentation during the first plenary session of the event. Barratt, the Mayer professor of renal medicine at the University of Leicester, presented “RNA Interference in IgAN” on the first day […]

Read More

September 21st, 2021

George Clinical Recognized as Finalist for Clinical Research Team of the Year Award

Citeline has named George Clinical as a finalist for their 2021 Clinical Research Team of the Year.  Citeline, a comprehensive global R&D intelligence firm provides insights into the global clinical trial landscape and the development of clinical trial programs, selected the DARE-19 team of George Clinical based on their compelling international accomplishments during the height […]

Read More

September 4th, 2021

GSK Sees Positive Results from Five Phase III Studies Conducted with George Clinical for Patients with Anemia Due to Chronic Kidney Disease

GlaxoSmithKline recently announced positive headline results from five studies of the Phase III ASCEND program conducted with George Clinical evaluating the efficacy and safety profile of daprodustat, an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) for patients with anemia due to chronic kidney disease (CKD). The ASCEND program showed that daprodustat met its primary […]

Read More

September 2nd, 2021

Add George Clinical to your network